Correction: Genetically engineered gas vesicle proteins with proliferative potential for synergistic targeted tumor therapy

IF 4.6 3区化学 Q2 CHEMISTRY, MULTIDISCIPLINARY

RSC Advances Pub Date : 2025-01-17 DOI:10.1039/D5RA90006A

Li Lin, Yan Du, Yaotai Wang, Yong Luo, Fujie Jiang, Haiyan Yang, Li Ren and Jianzhong Zou

引用次数: 0

Abstract

Correction for ‘Genetically engineered gas vesicle proteins with proliferative potential for synergistic targeted tumor therapy’ by Li Lin et al., RSC Adv., 2025, 15, 157–166, https://doi.org/10.1039/D4RA07532C.

查看原文本刊更多论文

更正：基因工程气体囊泡蛋白具有增殖性潜力，可用于协同靶向肿瘤治疗

李林等人对“具有增殖性靶向肿瘤治疗潜力的基因工程气体囊泡蛋白”的修正，RSC Adv., 2025, 15, 157-166, https://doi.org/10.1039/D4RA07532C。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

RSC Advances chemical sciences-

CiteScore

7.50

自引率

2.60%

发文量

3116

审稿时长

1.6 months

期刊介绍： An international, peer-reviewed journal covering all of the chemical sciences, including multidisciplinary and emerging areas. RSC Advances is a gold open access journal allowing researchers free access to research articles, and offering an affordable open access publishing option for authors around the world.